VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors
- 25 January 2016
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 35 (33) , 4379-4387
Abstract
We identify a limited subpopulation of epidermal cancer stem cells (ECS cells), in squamous cell carcinoma, that form rapidly growing, invasive and highly vascularized tumors, as compared with non-stem cancer cells. These ECS cells grow as non-attached spheroids, and display enhanced migration and invasion. We show that ECS cell-produced vascular endothelial growth factor (VEGF)-A is required for the maintenance of this phenotype, as knockdown of VEGF-A gene expression or treatment with VEGF-A-inactivating antibody reduces these responses. In addition, treatment with bevacizumab reduces tumor vascularity and growth. Surprisingly, the classical mechanism of VEGF-A action via interaction with VEGF receptors does not mediate these events, as these cells lack VEGFR1 and VEGFR2. Instead, VEGF-A acts via the neuropilin-1 (NRP-1) co-receptor. Knockdown of NRP-1 inhibits ECS cell spheroid formation, invasion and migration, and attenuates tumor formation. These studies suggest that VEGF-A acts via interaction with NRP-1 to trigger intracellular events leading to ECS cell survival and formation of aggressive, invasive and highly vascularized tumors.Keywords
This publication has 56 references indexed in Scilit:
- Role of VEGF Receptors in Normal and Psoriatic Human Keratinocytes: Evidence from Irradiation with Different UV SourcesPLOS ONE, 2013
- Multiple Roles for VEGF in Non-Melanoma Skin Cancer: Angiogenesis and BeyondJournal of Skin Cancer, 2012
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) InteractionJournal of Medicinal Chemistry, 2010
- Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivityBritish Journal of Cancer, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- The burden of skin diseases: 2004Journal of the American Academy of Dermatology, 2006
- Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth FactorCancer Research, 2006
- Self-renewal and solid tumor stem cellsOncogene, 2004
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002